Top Markets
Coin of the day
Oxurion N.V. Oxurion N.V.

Oxurion N.V.

OXUR
Hisse Senetlerindeki Sıralama #39565
Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a... Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a biopharmaceutical firm focused on researching, developing, and bringing to market treatments for various ocular conditions worldwide. Its primary commercialized offering is JETREA, a medication used to address vitreomacular adhesion and vitreomacular traction. The company's development pipeline includes THR-149, a plasma kallikrein inhibitor currently undergoing Phase II clinical trials for diabetic macular edema (DME), and THR-687, an integrin antagonist also in Phase II trials for DME. Oxurion has forged strategic partnerships with Bicycle Therapeutics, INC Research, and Galapagos NV. The organization was formerly known as ThromboGenics NV before officially changing its name to Oxurion NV in September 2018.
Hisse Fiyatı
$0.003084
Piyasa Değeri
$434.03K
Değişim (1 gün)
-7.14%
Değişim (1 yıl)
-89.24%
Ülke
BE
Ticaret Oxurion N.V. (OXUR)

Kategori

Oxurion N.V. (OXUR) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.00 - 2026-08-01

Gün sonu en düşük fiyat: $62.97K - 2006-07-01
Oxurion N.V. için hisse fiyatı geçmişi: 2006 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) 5.23%
2025 -96.55%
2024 -97.10%
2023 -94.05%
2022 -99.22%
2021 -35.88%
2020 10.67%
2019 -29.09%
2018 -4.13%
2017 62.47%
2016 -25.93%
2015 -55.06%
2014 -66.50%
2013 -54.24%
2012 123.36%
2011 -17.09%
2010 25.57%
2009 132.05%
2008 -27.90%
2007 10.78%
2006 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$517.18 32.51%
US
$857.76 31.47%
NL
$734.04 7.47%
CH
$1.07K -6.40%
KR
$257.75 13.87%
BE